Cell & Bioscience, 2023 · DOI: https://doi.org/10.1186/s13578-023-01011-9 · Published: April 3, 2023
Spinal cord injury (SCI) often leads to permanent loss of movement and sensation, and current treatments are limited. This study investigates how vascular endothelial cells, which line blood vessels, communicate with immune cells (microglia and macrophages) after SCI. The researchers found that exosomes, tiny vesicles released by these endothelial cells, can promote the polarization of microglia and macrophages towards an anti-inflammatory (M2) phenotype. This shift reduces inflammation and supports nerve regeneration in the injured spinal cord. Specifically, the study identifies a protein called USP13 within these exosomes as a key player. USP13 stabilizes IκBα, a protein that inhibits the NF-κB signaling pathway, thereby reducing inflammation and promoting recovery after SCI.
Exosomes derived from vascular endothelial cells may be a promising therapeutic approach for treating SCI.
Exosomes can be engineered to deliver specific proteins or drugs to the injured spinal cord, enhancing therapeutic efficacy.
Understanding the role of USP13 in regulating microglia/macrophage polarization can lead to new strategies for controlling neuroinflammation after SCI.